<DOC>
	<DOCNO>NCT00690703</DOCNO>
	<brief_summary>The study hypothesis radiofrequency ( RF ) ablation safe effective treatment malignant lung tumor .</brief_summary>
	<brief_title>Radiofrequency Ablation Pulmonary Tumors Response Evaluation</brief_title>
	<detailed_description>Image-guided RF ablation accept viable therapeutic choice patient early-stage hepatocellular carcinoma limit hepatic metastatic disease colorectal cancer , surgery preclude ( 1 , 2 ) . Recently , RF ablation propose viable option treatment pulmonary malignancy . Experimental study animal tumor model confirm effectiveness RF ablation destruction experimentally-induced pulmonary malignancy ( 3 ) . Pilot clinical investigation suggest treatment achieve high proportion tumor response ( 4 , 5 ) . We design prospective , intention-to-treat , multicenter clinical trial aim assess feasibility , safety effectiveness RF ablation treatment lung malignancy .</detailed_description>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>1. adult ( &gt; 18 year ) male female patient 2. patient biopsyproven NSCLC lung metastasis 3. patient reject surgery consider unfit radiation therapy chemotherapy 4. patient many 3 tumor per lung , 3.5 cm small great diameter , CT scan 5. tumor locate least 1 cm trachea ; main bronchus ; esophagus ; aorta ; aortic arch branch ; pulmonary artery ; heart 6. tumor accessible percutaneous route 7. patient Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 , 2 8. patient platelet count &gt; 100 x 109 /L international normalize ratio ≤ 1.5 9. patient sign write informed consent prior study specific procedure . 1. patient undergone previous pneumonectomy 2. patient consider highrisk RF ablation due major comorbid medical condition 3. patient 3 tumor / lung 4. patient least one tumor &gt; 3.5 great diameter 5. tumor associate atelectasis obstructive pneumonitis 6. patient renal failure require hemodialysis peritoneal dialysis 7. patient active clinically serious infection 8. patient history organ allograft 9. patient history substance abuse medical , psychological social condition may interfere / participation study evaluation study result 10. patient pregnant breastfeed 11. patient ECOG performance status &gt; 2 12. patient platelet count ≤ 100 x 109 /L international normalize ratio &gt; 1.5 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>non small cell lung cancer</keyword>
	<keyword>pulmonary metastasis</keyword>
	<keyword>radiofrequency ablation</keyword>
</DOC>